StockData
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31

Lantheus Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$99.92+0.22 (+0.22%)

Close on Oct 19, 2026

Market cap
$6.75B
P/E (TTM)
24.2
Dividend yield
–

Lantheus statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of In Vitro & In Vivo Diagnostic Substances companies for comparison

Valuation

MeasureLantheusIndustry median
Market Cap$6.52B$197.05M
Enterprise Value$6.50B$106.56M
PE Ratio24.1920.52
PS Ratio4.193.93
PB Ratio4.972.14
P/TBV Ratio17.012.46
P/OCF Ratio15.8013.78

Enterprise value

MeasureLantheusIndustry median
EV / Sales4.182.69
EV / EBITDA16.6314.86
EV / EBIT21.5019.00

Income (trailing twelve months)

MeasureLantheusIndustry median
Revenue$1.56B$57.94M
Gross Profit$936.02M$90.47M
Operating Income$302.34M-$21.44M
Pretax Income$362.98M-$14.45M
Net Income$275.31M-$22.46M
EBITDA$390.85M-$16.91M
EPS (Diluted)$4.13-$0.83

Margins

MeasureLantheusIndustry median
Gross Margin60.1%52.3%
Operating Margin19.4%-44.5%
Pretax Margin23.3%-13.0%
Profit Margin17.7%-39.2%
EBITDA Margin25.1%-31.3%

Returns

MeasureLantheusIndustry median
Return on Equity (ROE)22.2%-53.1%
Return on Assets (ROA)12.2%-41.0%
Return on Invested Capital (ROIC)19.7%-32.0%
Return on Capital Employed (ROCE)14.5%-37.8%

Growth

MeasureLantheusIndustry median
Revenue Growth (YoY)2.35%6.01%
Net Income Growth (YoY)1.59%-37.7%
EPS Growth (YoY)9.55%-29.2%
Revenue Growth (3Y CAGR)18.1%2.25%
Revenue Growth (5Y CAGR)35.3%6.42%
EPS Growth (3Y CAGR)104.3%-0.17%

Balance sheet

MeasureLantheusIndustry median
Cash & Short-Term Investments$593.30M$62.42M
Total Debt$571.05M$120.13M
Net Cash (Debt)$22.25M$15.68M
Net Cash Per Share$0.34$0.65
Equity (Book Value)$1.31B$48.79M
Book Value Per Share$20.10$1.36
Tangible Book Value$383.39M$23.06M
Working Capital$691.38M$75.77M

Financial position

MeasureLantheusIndustry median
Current Ratio3.063.30
Quick Ratio2.822.39
Debt / Equity0.440.51
Debt / EBITDA1.463.35
Net Debt / EBITDA-0.062.22
Interest Coverage15.26-7.12

Cash flow (trailing twelve months)

MeasureLantheusIndustry median
Operating Cash Flow$412.80M-$12.35M

Efficiency

MeasureLantheusIndustry median
Asset Turnover0.690.38
Inventory Turnover10.362.67
Revenue Per Employee$1.30M$398.96K
Profits Per Employee$230.77K-$732.08K
Employee Count1,19373

Dividends and yields

MeasureLantheusIndustry median
Earnings Yield4.22%-21.2%

Shares

MeasureLantheusIndustry median
Shares Outstanding65,272,40059,128,900
Shares Change (YoY)-6.90%11.1%
Shares Change (QoQ)0.29%0.54%
Float63,739,60048,744,500
Shares Held by Insiders2.35%11.8%
Shares Held by Institutions116.5%59.4%

Taxes

MeasureLantheusIndustry median
Income Tax$87.67M$91.50K
Effective Tax Rate24.2%20.6%

Scores

MeasureLantheusIndustry median
Graham Number$43.21$17.36
Graham Upside-56.8%-45.5%
Altman Z-Score5.460.10
Piotroski F-Score54
Beneish M-Score-2.25-2.62

Calculated by StockData from Lantheus's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.